ADAMI, Maristella
 Distribuzione geografica
Continente #
NA - Nord America 2.179
EU - Europa 2.007
AS - Asia 844
AF - Africa 58
SA - Sud America 3
OC - Oceania 2
Totale 5.093
Nazione #
US - Stati Uniti d'America 2.132
CN - Cina 646
IE - Irlanda 453
SE - Svezia 431
IT - Italia 295
FI - Finlandia 285
UA - Ucraina 283
DE - Germania 160
TR - Turchia 82
SG - Singapore 79
CI - Costa d'Avorio 55
GB - Regno Unito 49
CA - Canada 47
BE - Belgio 17
CZ - Repubblica Ceca 12
IN - India 12
JP - Giappone 8
AT - Austria 6
NL - Olanda 6
IL - Israele 5
IR - Iran 5
HK - Hong Kong 4
CL - Cile 3
FR - Francia 3
NG - Nigeria 2
RO - Romania 2
AU - Australia 1
CH - Svizzera 1
EG - Egitto 1
ES - Italia 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TH - Thailandia 1
Totale 5.093
Città #
Dublin 451
Chandler 401
Jacksonville 316
Dearborn 267
Parma 183
Ann Arbor 181
Nanjing 155
Ashburn 130
Beijing 103
Princeton 83
Izmir 80
San Mateo 68
Wilmington 59
Shanghai 56
Abidjan 55
Toronto 41
Nanchang 38
Boardman 34
Singapore 34
Shenyang 32
Woodbridge 31
Kunming 25
Helsinki 23
Jiaxing 23
Hebei 21
Jinan 21
Changsha 19
Hefei 19
Brussels 17
Hangzhou 16
Seattle 15
Tianjin 15
Guangzhou 13
Houston 13
Lucca 13
Brno 12
Des Moines 12
Auburn Hills 11
Norwalk 10
Bremen 8
Düsseldorf 8
Los Angeles 8
Fremont 7
Leawood 7
Milan 7
Augusta 6
Borås 6
Falls Church 6
Fuzhou 6
Orange 6
Ardabil 4
Grafing 4
Hong Kong 4
Ottawa 4
Rome 4
Vienna 4
Xian 4
Fountain Valley 3
Haikou 3
Munich 3
Washington 3
Amsterdam 2
Ardea 2
Bocsa 2
Caorso 2
Chengdu 2
Crispano 2
Drò 2
Hyderabad 2
Kocaeli 2
Lishui 2
Lonato 2
Mel 2
Monmouth Junction 2
Mumbai 2
Neviano degli Arduini 2
New York 2
Piacenza 2
Port Harcourt 2
Pune 2
Rockville 2
Sant'Ambrogio di Valpolicella 2
Taiyuan 2
Taizhou 2
Tappahannock 2
Taramani 2
Villafranca di Verona 2
Athlone 1
Birmingham 1
Castlerea 1
Changchun 1
Chisinau 1
Chongqing 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Fontanellato 1
Frankfurt am Main 1
Jinhua 1
Kampung Bota Kiri 1
Totale 3.276
Nome #
Treatments for COVID-19: emerging drugs against the coronavirus 156
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 – Triazine and 1H-indole like derivatives against the human histamine H4 receptor 110
CB1 and CB2 receptors and rat gastric acid secretion: "in vivo" study with selective agonists and antagonists 105
Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties 100
Gastroprotective effect of the histamine H4 receptor antagonist JNJ7777120 in mice 95
Cannabinoid receptors and gastric acid secretion: a functional study in the rat 93
Cannabinoid CB1 receptors and gastric acid secretion: in vivo and in vitro studies 88
Gastric and cardiovascular effects of COX-1 and COX-2 selective non steroidal anti-inflammatory drugs 88
Comparison of pharmacological activity of hydrochloride salt and free base of putative histamine H4 ligands 86
CB1 and CB2 receptors and rat gastric acid secretion: "in vitro" study and immunoistochemical localization 83
In situ investigation of the effects of icv application of cannabinoid receptor agonists on rat gastric acid secretion 82
Cannabinoid CB1 receptors are involved in the regulation of rat gastric acid secretion 82
Gastric and cardiovascular effects of cox-1 and cox-2 selective nonsteroidal anti-inflammatory drugs 81
Synthesis and pharmacological characterization of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities 80
Central and peripheral histamine in gastric functions 79
Gastroprotective effects of the selective histamine H4 receptor ligands ST-994 and ST-1012 in mouse in vivo model. 79
Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice 77
Role of CB1-cannabinoid receptors in the regulation of rat gastric acid secretion 77
Cannabinoid receptors and gastric acid secretion: a functional study in the rat 76
Role of histamine H3 receptors in the regulation of gastric functions 75
Role of CB1-cannabinoid receptors in the regulation of rat gastric acid secretion 73
Effects of histamine H4 receptor ligands in a mouse model of gastric ulceration 73
Involvement of histamine H1 and H4 receptors in a murine model of acute skin inflammation and pruritus 73
A new furoxan NO-donor rabeprazole derivative and related compounds 72
Pharmacological evidence for beta3 adrenoceptors in the control of rat gastric acid secretion 71
Histamine H3 receptors mediate antisecretory effects in the isolated rat stomach 70
Cardiac and gastric effects of hsitamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity 69
N-substituted piperidinyl alkyl imidazoles: discovery of a potent and highly selective histamine H3 receptor agonist 68
Effects of the H4 receptor antagonist JNJ7777120 in mice: focus on strain-related differenes 68
Antiinflammatory, analgesic and gastroprotective effects of the novel and selective histamine H4-receptor antagonist VUF5949 67
Effects of selective histamine H4 receptor ligands on croton oil-induced skin inflammation and pruritus in mice 67
Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach 65
Antiinflammatory, analgesic and gastroprotective effects of the novel and selective histamine H4-receptor antagonist VUF5949 65
Effect of histamine H4 receptor ligands on cholinergic neurotransmission of the rat duodenum 64
Effects of Cyclooxygenase-1 and -2 Inhibition on Gastric Acid Secretion and Cardiovascular Functions in Rats 64
Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. 63
Anti-inflammatory and gastroprotective effects of the H4 receptor antagonist JNJ7777120 in mice: focus on strain-related differences. 63
Inhibitory effects of the beta3-adrenoceptor agonists SR58611A and BRL37344 on rat gastric acid secretion 61
Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat 61
Involvement of histamine H1 and H4 receptors in a murine model of acute skin inflammation and pruritus 61
Neuronal histamine H3 receptors mediate antisecretory effects in the rat isolated gastric fundus 60
Role of histamine H4 receptors in the gastrointestinal tract 60
Antisecretory and gastroprotective activities of a nitric oxide (NO)-releasing derivative of the proton pump inhibitor rabeprazole 60
Investigation of CB1 cannabinoid receptors mediating antisecretory effects in rat stomach 59
Synthesis of 1,2-benzisothiazole derivatives and investigation of their putative histaminergic activity 58
Characterization of cholinoreceptors in the rat urinary bladder by the use of agonists and antagonists of the cholinergic system. 57
Neuronal histamine H3 receptors mediate antisecretory effects in the isolated rat gastric fundus 55
Effects of new H4 receptor ligands: in vitro and in vivo studies 55
Effects of histamine H4 receptor agonists and antagonists on carrageenan-induced inflammation in rats 55
Nitric oxide-releasing rabeprazole: antisecretory and gastroprotective activities 54
Comparison of the in Vitro and in Vivo H2-H4 receptor selectivity of 4-methylhistamine and VUF 8430 53
Gastroprotective effects of histamine H4 receptor ligands in rodent ulcer models 51
Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation 50
Involvement of histamine H3 receptors in the gastro-protection induced by ghrelin in the conscious rat 50
Antiinflammatory, analgesic and gastric effects of the novel and selective histamine H4-receptor antagonists VUF10214 and VUF10148 49
Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat 49
Peripheral actions and therapeutic potential in periphery 48
The histamine H4 receptor: a new target for gastrosparing anti-inflammatory drugs? 48
Gastric effects of the histamine H4 receptor antagonists JNJ7777120 and VUF6002. 47
Gastric effects of the highly selective histamine H3 receptor agonist methimepip. 47
Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. 46
Gastric effects of Histamine: any role for H4 receptors? 46
Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430 46
Human defunctionalized colon: a histopathological and pharmacological study ofmuscularis propria in resection specimens 46
Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion. 46
Strain-dependent effects of the histamine H(4) receptor antagonist JNJ7777120 in a murine model of acute skin inflammation 46
Histamine H4 receptors are not involved in the regulation of cholinergic neurotransmission in the rat duodenum 44
Fragment optimization leading to H4 receptor ligands with differential pharmacology 44
Histamine H3 receptors are involved in the protective effect of ghrelin against HCl-induced gastric damage in rats 43
Measurement of gastric acid secretion in the anaesthetized rat 43
Probing the histamine H4 receptor binding site: from fragments to active ligands 42
Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists 41
Effects of histamine H3 and H4 receptor ligands in the rodent gastric mucosa 40
Gastroprotective effects of selective histamine H3 receptor agonists methimepip and immethridine 39
Histamine in cancer 39
Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo 39
Effects of histamine H4 receptor ligands on rodent models of acute inflammation 39
The histamine H4 receptor: a new target for GI safe anti-inflammatory drugs 38
Histamine H4 receptor affinity of 1,3,5-triazine derivatives. 38
Functional and histologic assessment of rat gastric mucosa after chronic treatment with sulphurous thermal water 38
Mixed antisecretory and gastroprotective activities of a new H2- antagonist containing a nitric oxide-donor furoxan moiety 37
The Histamine H4 Receptor: A Novel Target for Safe Anti-inflammatory Drugs? 36
Selective histamine H3 and H4 receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach 33
Totale 5.144
Categoria #
all - tutte 16.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.099 200 62 68 32 111 174 166 32 98 52 32 72
2020/2021573 6 73 50 9 82 18 70 13 118 11 108 15
2021/2022486 18 1 3 20 22 20 131 61 20 38 35 117
2022/20231.603 188 171 100 144 102 195 28 85 524 9 43 14
2023/2024472 23 48 16 5 45 84 48 34 25 47 33 64
2024/202588 88 0 0 0 0 0 0 0 0 0 0 0
Totale 5.144